HEALTH● LOWJul 17 · Jul 17, 2026, 3:59 PM
Novartis wins full FDA approval for kidney disease drug Fabhalta in IgA nephropathy
Seeking Alpha Tech
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH21m agoNigeria Could Be Declared Ebola-Free By December — FGChannels TVHEALTH34m agoEbola won’t be used as political weapon — NCDC chiefVanguard NigeriaHEALTH45m agoDeadly parasite: how fox tapeworm warns of pandemic XEuroNews [en]HEALTH58m agoBlood test could reveal prostate cancer risk more than a decade before diagnosisEuroNews [en]